Navigation Links
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
Date:6/17/2011

f 60 Tablets

50458-593-60

OlG175

August 2012RISPERDAL® (risperidone) is used for the treatment of schizophrenia in adults and adolescents ages 13-17 years.

RISPERDAL® (risperidone) is used alone or in combination with other medicines (valproate or lithium) in adults for the short-term treatment of bipolar mania; or alone in adults, children and adolescents ages 10-17 years for the short-term treatment of bipolar mania.

RISPERDAL® (risperidone) is used for the treatment of irritability associated with autistic disorder in children and adolescents ages 5-16 years.

Ortho-McNeil-Janssen Pharmaceuticals, Inc. has initiated these recalls in the U.S. and Puerto Rico at the wholesale and retail (pharmacy) level and is communicating this information to these customers.  The company does not anticipate a product shortage resulting from this action.

Patients should not stop taking their medication.  Anyone experiencing an uncharacteristic odor associated with RISPERDAL® 3mg Tablets or risperidone 2mg Tablets should return the tablets to their pharmacist, and contact their healthcare professional if they have questions.  Patients or healthcare professionals can contact the Medical Information Recall Line at 1-800-634-8977 (Monday – Friday, 9 am – 5 pm ET).  Information can also be found on www.risperdal.com and www.patriotpharmaceuticals.com

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program online, or through regular mail or by fax.

  • Online:  www.fda.gov/medwatch/report.htm
  • Regular Mail:  Use postage-paid, pre-addressed Form FDA 3500 available at:  w
    '/>"/>

  • SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
    2. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
    3. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
    4. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
    5. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
    6. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
    7. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
    8. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
    9. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
    10. Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
    11. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
    (Date:5/23/2013)... 23, 2013  The need to add tissue ... was highlighted prominently at the 108 th ... in San Diego.  According to SonaCare Medical, a ... (HIFU) technology, the need for image-guided technologies to ... to consider minimally invasive ablative treatments, was addressed ...
    (Date:5/23/2013)...  Hologic, Inc. (Hologic or the Company) (NASDAQ: ... and supplier of premium diagnostics, medical imaging systems ... the healthcare needs of women, today announced that ... clinical practice comparing breast cancer screening with Hologic,s ... mammography alone showed a significant reduction in recall ...
    Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
    ... in Psychiatry , , HARTFORD, Conn., ... current issue of the Future Medicine Group (London) journal ... are helping to point the way toward the application of DNA-guided ... The Institute of Living of Hartford Hospital in collaboration with Genomas. ...
    ... The Takeda Oncology Company today reported updated results ... the large, international Phase III VISTA(1) trial showing ... multiple myeloma given VELCADE, melphalan and prednisone (VcMP). ... patient sub-groups, including those with poor prognostic characteristics, ...
    Cached Medicine Technology:Genomas Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
    (Date:5/24/2013)... Atlanta, GA (PRWEB) May 24, 2013 Started ... convention held in Orlando. 2013 marks AMTC’s 31st anniversary. ... same family, starting with supermodel Millie Lewis and her daughter, ... by top agents, managers, casting directors, and music professionals including ... Dramatic Arts and XP Media. They are kings of Hollywood ...
    (Date:5/24/2013)... failed to replicate what appeared to be breakthrough results ... were published last year in the journal Science ... suggested that the drug bexarotene (marketed as Targretin) could ... a pathological hallmark of Alzheimer,s disease in ... the 2012 report, drug treatment quickly removed most of ...
    (Date:5/24/2013)... City, Utah (PRWEB) May 24, 2013 ... , with exciting new enhancements for instructors and students. ... stay more focused through personalize learning plan templates, targeted ... AnatomyOne release provides 500 new assessment questions, 5,000 searchable ... review notes. , AnatomyOne 2.0 is the ...
    (Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...
    (Date:5/24/2013)... (PRWEB) May 24, 2013 Dwell ... VP, Brandon Huff as Executive Vice President of Digital ... business units, which represented a large portion of Yahoo's ... growth as Dwell develops a fully-integrated commerce unit to ... of experience monetizing digital content for leading firms in ...
    Breaking Medicine News(10 mins):Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2
    ... system for measuring brain tissue with magnetic resonance imaging ... at an earlier stage according to a new study ... Radiology . , In Alzheimer,s disease, nerve cell death ... especially the hippocampus region, to shrink. MRI with high ...
    ... XM 157 on XM Satellite Radio,and The United ... of a new 13 week programming series designed ... clinical trauma, internal,medicine, medical education and much more., ... and educate medical,professionals and those interested in a ...
    ... 23 Colonial Life & Accident,Insurance Company has set up dedicated ... in the Midwest to get support from the,company., (Logo: ... centers toll free at these,numbers:, Policyholders: ... Brokers: ...
    ... They resulted in 8,000 deaths, 56,000 hospitalizations for those ... June 23 (HealthDay News) -- In 2005, traumatic brain ... deaths and 56,000 hospitalizations among Americans age 65 and ... and Prevention study. , TBIs accounted for ...
    ... Medical Association Provides Tips on Caring for Your ... ... teenagers,love horses and often parents buy or lease a horse for their ... of a horse can be wonderful but a,time-consuming responsibility," said Dr. Jeff ...
    ... prohibitive, experts say , , MONDAY, June 23 (HealthDay News) -- ... overall death risk for American adults, a new study suggests. ... of who will have a problem and who will not," ... at the Harbor-UCLA Medical Center. , He and his colleagues ...
    Cached Medicine News:Health News:Automated MRI technique assists in earlier Alzheimer's diagnosis 2Health News:The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called 'The Strength to Heal' That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio. 2Health News:The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called 'The Strength to Heal' That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio. 3Health News:Support Numbers for Colonial Life & Accident Insurance Company Customers Affected by Floods 2Health News: Senior Falls Can Lead to Brain Injury 2Health News:Saddle Up! Getting a Jump on Proper Horse Care 2Health News:Arterial Calcium Scans Can Predict Death Risk 2Health News:Arterial Calcium Scans Can Predict Death Risk 3Health News:Arterial Calcium Scans Can Predict Death Risk 4
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: